Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer

Overview

Fatigue is one of the most common and distressing symptoms in teenage and young adult cancer patients. Despite this, there has been virtually no research evaluating treatment for cancer-related fatigue in this young patient group. The investigators are undertaking a small qualitative study to co-design a fatigue intervention, that will then be evaluated in future research to assess its effectiveness.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: February 2017

Detailed Description

This small qualitative study will involve 7-10 patients who are within one year of completing cancer treatment, as well as some parents. Participants will be recruited from one centre, the Cambridge Teenage and Young Adult cancer Principal Treatment Centre. The three phases will involve a) participants being interviewed individually and attending a focus group, b) patients receiving the prototype co-designed intervention, and c) participants being interviewed after the intervention to provide feedback to allow further refinement of the intervention. The intervention will be delivered by an Allied Health Professional in the setting that participants have chosen. It is likely to involve, at a minimum, education about fatigue and support with increasing activity. It will not include administration of any medication.

Interventions

  • Behavioral: Fatigue Intervention
    • The Fatigue Intervention will include education, energy conservation and activity promotion

Arms, Groups and Cohorts

  • Experimental: Fatigue intervention
    • Fatigue Intervention is to be co-designed by participants, and likely to include education, energy conservation and activity promotion. Participants will also decide the name of the Fatigue Intervention

Clinical Trial Outcome Measures

Primary Measures

  • Participant-reported feedback on design content as assessed via interviews
    • Time Frame: 3 months
  • Participant-reported feedback on design acceptability as assessed via interviews
    • Time Frame: 3 months

Participating in This Clinical Trial

Inclusion Criteria

Patients:

  • Aged 16-27 with a diagnosis of cancer – Currently or previously known to the Cambridge Teenage and Young Adult cancer service – Primary cancer treatment completed within one year of recruitment OR on maintenance treatment for leukaemia. – A screening score of ≥5 in a 10-item numerical rating scale of fatigue severity over the last month – Able to give informed consent Parents: – The parent of a patient participant or a patient who would be eligible to participate – The patient consents to the parent being approached about the study – The parent is able to give informed consent Exclusion Criteria:

  • Current participation in another clinical trial

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: 27 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Anna Spathis
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Anna Spathis, Consultant in Palliative Medicine – Cambridge University Hospitals NHS Foundation Trust
  • Overall Official(s)
    • Anna Spathis, MA MB BChir, Principal Investigator, Cambridge University Hospitals NHS Foundation Trust

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.